Skip to main content

Table 4 Mean, standard error (SE) and p-values of pre-post intervention differences and treatment effect

From: An evidence-based self-management package for urinary incontinence in older women: a mixed methods feasibility study

Variable

Dimensions

Baseline differencea

Follow-up differencea

Treatment effectc

ORb/Coef.

SE

p-value

ORb/Coef.

SE

p-value

ORb/Coef.

SE

p-value

EQ-5D-5L

Mobility

         

No/slight problem

         

Moderate/Severe/extreme problem

1.33

0.92

0.675

0.57

0.45

0.481

0.32

0.33

0.267

Selfcare

         

No/slight problem

         

Moderate/Severe/extreme problem

         

Usual activities

         

No/slight problem

         

Moderate/Severe/extreme problem

1.38

1.02

0.663

1.05

0.81

0.950

0.74

0.77

0.774

Pain & discomfort

         

No/slight problem

         

Moderate/Severe/extreme problem

1.84

1.12

0.317

1.30

0.85

0.683

0.63

0.62

0.637

Anxiety & depression

         

No/slight problem

         

Moderate/Severe/extreme problem

0.63

0.46

0.526

1.05

0.91

0.957

1.24

1.14

0.811

Index

0.02

0.05

0.643

0.04

0.05

0.471

0.02

0.03

0.540

VAS

7.27

6.35

0.258

5.54

4.66

0.240

3.82

4.51

0.402

KHQ

Part I

         

General health perception (0-100)

1.33

5.35

0.804

-0.79

6.30

0.900

-1.63

5.38

0.763

Incontinence impact (0-100)

-11.11

6.44

0.091

-3.50

6.79

0.609

3.07

6.26

0.626

Part II

         

Role limitations (0-100)

-13.19

6.66

0.054

-10.53

6.71

0.123

-1.06

4.96

0.831

Physical limitations (0-100)

-7.75

6.17

0.216

-9.75

6.76

0.156

-3.82

4.96

0.446

Social limitations (0-100)

-7.42

5.64

0.195

-2.67

4.80

0.581

1.66

3.61

0.648

Personal relationships (0-100)

-6.35

7.37

0.396

-5.21

2.93

0.086

-3.89

2.19

0.088

Emotions (0-100)

-0.93

5.09

0.856

-3.94

5.01

0.435

-3.44

3.24

0.294

Sleep/energy (0-100)

-9.83

8.67

0.263

-10.25

8.90

0.255

-3.68

6.92

0.598

Severity measures (0-100)

-14.64

6.44

0.028

-10.94

5.55

0.055

-1.36

3.86

0.725

Part III

         

Symptom severity scale (0-30)

-1.92

1.21

0.119

-2.67

0.93

0.006

-1.77

0.76

0.025

ICIQ-UI SF

Scale (0-21)

-1.06

1.18

0.374

-2.39

1.01

0.022

-1.87

0.84

0.031

GSE-UI

Scale (0-120)

27.20

6.11

0.000

20.05

7.05

0.007

-4.90

5.16

0.348

HADS

Anxiety scale (0-21)

-0.44

1.38

0.755

-2.68

1.32

0.049

-2.31

0.66

0.001

Normal

         

Ill

0.92

0.53

0.879

0.47

0.31

0.245

0.34

0.28

0.188

Depression scale (0-21)

-0.21

1.05

0.840

-0.36

1.03

0.732

-0.17

0.46

0.715

Normal

         

Ill

2.30

2.11

0.364

1.05

0.91

0.957

0.44

0.54

0.505

  1. VAS Visual Analogue Scale, KHQ King’s Health Questionnaire, ICIQ-UI SF International Consultation on Incontinence Questionnaire – urinary incontinence short form, GSE-UI Geriatric Self-Efficacy index for urinary incontinence, HADS Hospital Anxiety and Depression ScaleaDifference=intervention-control; bOR: odds ratio; cFor each outcome, analysis of covariance (ANCOVA) model with the baseline outcome was used to estimate the treatment effect
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us